NYSEARCA:LABD

Direxion Daily S&P Biotech Bear 3x Shares Stock Forecast, Price & News

$19.34
-0.12 (-0.62 %)
(As of 09/22/2021 12:00 AM ET)
Add
Today's Range
$18.76
$19.82
50-Day Range
$17.17
$26.91
52-Week Range
$12.30
$69.21
Volume2.54 million shs
Average Volume3.10 million shs
Market Capitalization$59.30 million
P/E RatioN/A
Dividend Yield0.00%
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive LABD News and Ratings via Email

Sign-up to receive the latest news and ratings for Direxion Daily S&P Biotech Bear 3x Shares and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer Direxion
Fund NameDirexion Daily S&P Biotech Bear 3x Shares
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:LABD
Inception Date5/28/2015
Fund ManagerPaul Brigandi, Tony Ng
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkS&P Biotechnology Select Industry Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$61.46 million
Average Daily Volume$3.82 million
Discount/Premium0.05%

ETF Expenses

Management Fee0.75%
Other Expenses0.39%
Total Expenses1.14%
Fee Waiver-0.03%
Net Expenses1.11%

Administrator, Advisor and Custodian

AdministratorU.S. Bancorp Fund Services, LLC
AdvisorRafferty Asset Management, LLC
CustodianThe Bank of New York Mellon Corporation
DistributorForeside Fund Services, LLC
Transfer AgentThe Bank of New York Mellon Corporation
Trustee
Lead Market MakerVirtu Financial

Currency Exposure of LABD

speech bubbles
speech bubbles











Direxion Daily S&P Biotech Bear 3x Shares (NYSEARCA:LABD) Frequently Asked Questions

What stocks does MarketBeat like better than Direxion Daily S&P Biotech Bear 3x Shares?

Wall Street analysts have given Direxion Daily S&P Biotech Bear 3x Shares a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Direxion Daily S&P Biotech Bear 3x Shares wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Direxion Daily S&P Biotech Bear 3x Shares' stock been impacted by Coronavirus?

Direxion Daily S&P Biotech Bear 3x Shares' stock was trading at $364.60 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, LABD shares have decreased by 94.7% and is now trading at $19.34.
View which stocks have been most impacted by COVID-19
.

When did Direxion Daily S&P Biotech Bear 3x Shares' stock split? How did Direxion Daily S&P Biotech Bear 3x Shares' stock split work?

Direxion Daily S&P Biotech Bear 3x Shares's stock reverse split on the morning of Friday, August 28th 2020. The 1-20 reverse split was announced on Monday, July 27th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, August 27th 2020. An investor that had 100 shares of Direxion Daily S&P Biotech Bear 3x Shares stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Direxion Daily S&P Biotech Bear 3x Shares own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Direxion Daily S&P Biotech Bear 3x Shares investors own include Direxion Daily S&P Biotech Bull 3x Shares (LABU), Micron Technology (MU), Intel (INTC), Gilead Sciences (GILD), (SNY), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), Pfizer (PFE), Direxion Daily Semiconductors Bull 3x Shares (SOXL) and ProShares UltraPro Short QQQ (SQQQ).

What is Direxion Daily S&P Biotech Bear 3x Shares' stock symbol?

Direxion Daily S&P Biotech Bear 3x Shares trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "LABD."

Who are Direxion Daily S&P Biotech Bear 3x Shares' major shareholders?

Direxion Daily S&P Biotech Bear 3x Shares' stock is owned by many different retail and institutional investors. Top institutional shareholders include Susquehanna International Group LLP (0.00%), Virtu Financial LLC (2.63%), Citadel Advisors LLC (0.00%), Wolverine Trading LLC (0.00%), Flow Traders U.S. LLC (0.90%) and Cutler Group LP (0.00%).

Which institutional investors are selling Direxion Daily S&P Biotech Bear 3x Shares stock?

LABD stock was sold by a variety of institutional investors in the last quarter, including Wolverine Trading LLC, Cutler Group LP, Citadel Advisors LLC, Simplex Trading LLC, Morgan Stanley, and Morgan Stanley.

Which institutional investors are buying Direxion Daily S&P Biotech Bear 3x Shares stock?

LABD stock was acquired by a variety of institutional investors in the last quarter, including Virtu Financial LLC, Flow Traders U.S. LLC, Susquehanna International Group LLP, Bank of America Corp DE, and Qube Research & Technologies Ltd.

How do I buy shares of Direxion Daily S&P Biotech Bear 3x Shares?

Shares of LABD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Direxion Daily S&P Biotech Bear 3x Shares' stock price today?

One share of LABD stock can currently be purchased for approximately $19.34.

How much money does Direxion Daily S&P Biotech Bear 3x Shares make?

Direxion Daily S&P Biotech Bear 3x Shares has a market capitalization of $59.30 million.


This page was last updated on 9/22/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.